Changes to insulin sensitivity in glucose clearance systems and redox following dietary supplementation with a novel cysteine-rich protein: A pilot randomized controlled trial in humans with type-2 diabetes.

We recently developed a novel keratin-derived protein (KDP) rich in cysteine, glycine, and arginine, with the potential to alter tissue redox status and insulin sensitivity. The KDP was tested in 35 human adults with type-2 diabetes mellitus (T2DM) in a 14-wk randomised controlled pilot trial comprising three 2×20 g supplemental protein/day arms: KDP-whey (KDPWHE), whey (WHEY), non-protein isocaloric control (CON), with standardised exercise. Outcomes were measured morning fasted and following insulin-stimulation (80 mU/m2/min hyperinsulinaemic-isoglycaemic clamp). With KDPWHE supplementation there was good and very-good evidence for moderate-sized increases in insulin-stimulated glucose clearance rate (GCR; 26%; 90% confidence limits, CL 2%, 49%) and skeletal-muscle microvascular blood flow (46%; 16%, 83%), respectively, and good evidence for increased insulin-stimulated sarcoplasmic GLUT4 translocation (18%; 0%, 39%) vs CON. In contrast, WHEY did not effect GCR (-2%; -25%, 21%) and attenuated HbA1c lowering (14%; 5%, 24%) vs CON. KDPWHE effects on basal glutathione in erythrocytes and skeletal muscle were unclear, but in muscle there was very-good evidence for large increases in oxidised peroxiredoxin isoform 2 (oxiPRX2) (19%; 2.2%, 35%) and good evidence for lower GPx1 concentrations (-40%; -4.3%, -63%) vs CON; insulin stimulation, however, attenuated the basal oxiPRX2 response (4%; -16%, 24%), and increased GPx1 (39%; -5%, 101%) and SOD1 (26%; -3%, 60%) protein expression. Effects of KDPWHE on oxiPRX3 and NRF2 content, phosphorylation of capillary eNOS and insulin-signalling proteins upstream of GLUT4 translocation AktSer437 and AS160Thr642 were inconclusive, but there was good evidence for increased IRSSer312 (41%; 3%, 95%), insulin-stimulated NFκB-DNA binding (46%; 3.4%, 105%), and basal PAK-1Thr423/2Thr402 phosphorylation (143%; 66%, 257%) vs WHEY. Our findings provide good evidence to suggest that dietary supplementation with a novel edible keratin protein in humans with T2DM may increase glucose clearance and modify skeletal-muscle tissue redox and insulin sensitivity within systems involving peroxiredoxins, antioxidant expression, and glucose uptake.

Vibration therapy reduces plasma IL6 and muscle soreness after downhill running.

OBJECTIVE: In this study, the effects of vibration therapy (VT) on delayed-onset muscle soreness (DOMS) and associated inflammatory markers after downhill running were determined. METHODS: 29 male recreational runners (33 (8) years; V(O2)peak 57 (6) ml kg(-1) min(-1)) completed a 40-min downhill run and were randomly allocated to a VT group or Control group. For 5 days post-run, the VT group underwent once-daily sessions of VT on the upper and lower legs. DOMS was assessed pre-run and for 5 days post-run by visual analogue scale. Immune cell subsets and plasma inflammatory markers were assessed pre-run, post-run, 24 and 120 h post-run by full differential cell count, and by ELISA and enzyme immunoassay, respectively. Data were analysed as per cent change from pre-run (ANOVA) and the magnitude of the treatment effect (Cohen's effect size statistics). RESULTS: VT significantly reduced calf pain 96 h post-run (-50% (40%), 90% confidence limits) and gluteal pain 96 h (-50% (40%)) and 120 h post-run (-30% (30%)); decreased interleukin 6 (IL6) 24 h (-46% (31%)) and 120 h post-run (-65% (30%)); substantially decreased histamine 24 h (-40% (50%)) and 120 h post-run (-37% (48%)); substantially increased neutrophils (8.6% (8.1%)) and significantly decreased lymphocytes (-17% (12%)) 24 h post-run. There were no clear substantial effects of VT on other leukocyte subsets and inflammatory markers. CONCLUSION: VT reduces muscle soreness and IL6. It may stimulate lymphocyte and neutrophil responses and may be a useful modality in treating muscle inflammation.

Short-term suppression of plasma free fatty acids fails to improve insulin sensitivity when intramyocellular lipid is elevated.

AIMS: Metabolic responses to manipulation of the plasma free fatty acid (FFA) concentration were assessed in six healthy men via cross-over design to determine whether FFAs independently influence insulin sensitivity. METHODS: Intramyocellular lipid (IMCL) was measured by proton magnetic resonance spectroscopy and insulin sensitivity via frequently sampled intravenous glucose tolerance test (IVGTT) after 67 h of two identical low carbohydrate/high fat (LC) diets which were used to elevate IMCL and plasma FFAs. To uncouple the influence of FFAs and IMCL on insulin sensitivity, FFAs were suppressed 30 min prior to and during IVGTT in one treatment [LC + nicotinic acid (NA)] by NA ingestion. RESULTS: Vastus lateralis IMCL was significantly elevated in LC (13.3 +/- 1.1 x 10(-3)) and LC + NA (13.5 +/- 1.1 x 10(-3)) (P < 0.01 for both), but was not different between conditions (P > 0.05). Plasma FFAs were raised in LC (0.79 +/- 0.08 mmol/l) and LC + NA (0.80 +/- 0.11 mmol/l) (P < 0.01 for both) and were significantly reduced by NA ingestion prior to (0.36 +/- 0.05 mmol/l, P < 0.01) and during IVGTT (P < 0.05) in LC + NA. Despite marked differences in plasma FFA availability, insulin sensitivity and glucose tolerance were not different between LC and LC + NA (P > 0.05 for both). CONCLUSIONS: Plasma FFAs appear to exert no immediate effect on insulin sensitivity/glucose tolerance independent of their action on intracellular lipid moieties. Further research is required to elucidate the duration of FFA suppression required to restore insulin sensitivity following lipid-induced insulin resistance.

Leg heating and cooling influences running stride parameters but not running economy.

To evaluate the effect of temperature on running economy (RE) and stride parameters in 10 trained male runners (VO2peak 60.8 +/- 6.8 ml . kg (-1) . min (-1)), we used water immersion as a passive temperature manipulation to contrast localised pre-heating, pre-cooling, and thermoneutral interventions prior to running. Runners completed three 10-min treadmill runs at 70 % VO2peak following 40 min of randomised leg immersion in water at 21.0 degrees C (cold), 34.6 degrees C (thermoneutral), or 41.8 degrees C (hot). Treadmill runs were separated by 7 days. External respiratory gas exchange was measured for 30 s before and throughout the exercise and stride parameters were determined from video analysis in the sagittal plane. RE was not affected by prior heating or cooling with no difference in oxygen cost or energy expenditure between the temperature interventions (average VO2 3rd-10th min of exercise: C, 41.6 +/- 3.4 ml . kg (-1) . min (-1); TN, 41.6 +/- 3.0; H, 41.8 +/- 3.5; p = 0.94). Exercise heart rate was affected by temperature (H > TN > C; p < 0.001). During minutes 3 - 5 of running the respiratory-exchange and minute ventilation/oxygen consumption ratios were greater in cold compared with thermoneutral (p < 0.05). Averaged over the full 10 min of exercise, stride length was shorter and stride frequency higher for the C trial compared to TN and H (p < 0.01). Leg temperature manipulation did not influence running economy despite changes in stride parameters that might indicate restricted muscle-tendon elasticity after pre-cooling. Larger changes in stride mechanics than those produced by the current temperature intervention are required to influence running economy.

Physical and physiological factors associated with success in the triathlon.

The physiological demands of sequential exercise in swimming, cycling and running are unique and require the triathlete to develop physical and physiological characteristics that are a blend of those seen in endurance swimming, cycling and running specialists. Elite triathletes are generally tall, of average to light weight and have low levels of body fat, a physique which provides the advantages of large leverage and an optimal power to surface area or weight ratio. Triathletes have high maximum oxygen uptake (VO2max) values, but VO2max may be on average marginally lower than values previously observed in endurance specialists. Although VO2max is a predictor of performance in triathletes of mixed abilities, it cannot be used to predict performance within homogenous groups of elite performers. Nevertheless, elite triathletes have significantly higher VO2max values than sub-elite triathletes and high VO2max levels are required for success in triathlons. The ability of the triathlete to exercise at a lower percentage of VO2max for a given submaximal workload may be especially important to triathlon success. This is influenced not only by VO2max itself, but also by anaerobic threshold and economy of movement. Anaerobic threshold, as indicated by either ventilatory threshold or lactate threshold, improves with triathlon training and when measured in the appropriate exercise mode has been related to swim, cycle and run performance in the triathlon. Economy of movement in swimming, cycling and running is also related to triathlon performance, and swimming economy in particular appears to be an area where triathletes could make large improvements. Future research should utilise experimental methodologies to investigate triathlon physiology, in particular, the influence of sequential exercise in different exercise modes on physiological function and examine the influence of different training interventions on triathlon physiology and performance.